Amira M. Badr
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 9
- Ginger and Zingiberaceae research 5
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities 3
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications 5
-
- Chemotherapy-induced organ toxicity mitigation 12
-
- Reproductive Biology and Fertility 4
-
- Liver Disease Diagnosis and Treatment 4
-
- Genomics, phytochemicals, and oxidative stress 3
- Co-authors
- Ebtehal El‐DemerdashEman M. MantawyWesam M. El‐BaklyAhmed EsmatHala AttiaYasmen F. MahranDalia FouadEman A. Mohamed
- Partner nations
- Saudi ArabiaEgyptUnited States
In The Last Decade
Amira M. Badr
47 papers receiving 991 citations
Peers
Comparison fields: 5 of 106
- Pharmacology 125
- Complementary and alternative medicine 91
- Biochemistry 58
- Biological Psychiatry 23
- Molecular Medicine 44
Countries citing papers authored by Amira M. Badr
This map shows the geographic impact of Amira M. Badr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amira M. Badr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amira M. Badr more than expected).
Fields of papers citing papers by Amira M. Badr
This network shows the impact of papers produced by Amira M. Badr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amira M. Badr. The network helps show where Amira M. Badr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amira M. Badr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 14 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 105 | |
| 14 | 2020 | 35 | |
| 15 | 2019 | 63 | |
| 16 | 2019 | 10 | |
| 17 | 2019 | 34 | |
| 18 | 2019 | 18 | |
| 19 | 2019 | 34 | |
| 20 | 2019 | 21 |
About Amira M. Badr
Amira M. Badr is a scholar working on Pharmacology, Molecular Medicine, Pathology and Forensic Medicine, Biochemistry and Complementary and alternative medicine, having authored 51 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (12 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Ginger and Zingiberaceae research (5 papers), Curcumin's Biomedical Applications (5 papers), Reproductive Biology and Fertility (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Phytochemicals and Antioxidant Activities (3 papers). The work is most often cited by research in Pharmacology (125 citations), Complementary and alternative medicine (91 citations), Biochemistry (58 citations), Biological Psychiatry (23 citations) and Molecular Medicine (44 citations). Amira M. Badr has collaborated with scholars based in Saudi Arabia, Egypt and United States. Frequent co-authors include Ebtehal El‐Demerdash, Eman M. Mantawy, Wesam M. El‐Bakly, Ahmed Esmat, Hala Attia, Yasmen F. Mahran, Dalia Fouad, Eman A. Mohamed, Hebatalla I. Ahmed and Nouf M. Al‐Rasheed. Their work appears in journals such as Pharmaceuticals, Dose-Response, Scientific Reports, European Journal of Pharmacology and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.